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Summary
nterleukin 4 (IL4), also known as B cell-stimulating factor
1 (BSF-1)' (1, 2), was originally defined by its ability to
induce the proliferation of anti-IgM-activated B cells (3). How-
ever, this T cell-derived lymphokine is now known to dis-
play diverse biological effects on a broad array of cell types,
including T lymphocytes (4, 5), mast cells (5), macrophages
(6), and hematopoietic progenitor cells (7).
In T cells, the functional role of IL4 as a growth factor
alternative to IL-2 has been proposed (8). Thus, IL4 is able
to support proliferation of several T cell lines (5, 9, 10), and
promotes T cell growth upon activation by phorbol esters
or lectins, both in mice (11-13) and humans (14). In addi-
tion, IL4 appears to be involved in the generation of specific
cytolytic activity (15, 16), as well as in the induction of CD8
expression in human CD4+ T cell clones (17), suggesting
a putative role for this lymphokine as a cytotoxic T cell differen-
tiation factor specific for CD8 + lymphocytes (18).
Recently, accumulating evidence indicates that IL4 may
also be involved in T cell development. As previously described
for IL-2, several groups have shown the growth-promoting
activity of ILA in different subsets of adult thymocytes (14,
19, 20). More importantly, IL4 appears to induce both growth
and differentiation of fetal intrathymic Thy-1 -CD4-CD8-
T cell precursors into CD8+ cytolytic T cells (21). These
data, together with the observation that production of IL4
(19, 22, 23), as well as expression of specific IL4 receptors
'Abbreviation used in this paper. BSF-1, B cell-stimulating factor 1.
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We have analyzed the effect of human recombinant interleukin 4 (rIL4) on the growth and
differentiation of human intrathymic pre-T cells (CD7+2+1-3-4-8-). We describe that this
population of T cell precursors proliferates in response to rIL4 (in the absence of mitogens or
other stimulatory signals) in a dose-dependent way. The IL-4-induced proliferation is independent
of the IL-2 pathway, as it cannot be inhibited with an anti-IL2 receptor a chain antibody. In our
culture conditions, rIL4 also promotes the differentiation of preT cells into phenotypically mature
T cells. Although both CD3/T cell receptor (TCR)-u/R+ and CD3-y/S+ T cells were ob-
tained, the preferential differentiation into TCR-y/a+ cells was a consistent finding. These re-
sults suggest that, in addition to IL-2, IL4 plays a critical role in promoting growth and differen-
tiation of intrathymic T cell precursors at early stages of T cell development.
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(IL4R) (20), occurs at early intrathymic developmental stages
in the mouse, suggest that IL-4 may play an important role
in T cell ontogeny.
In this report, the potential effects of IL-4 on the genera-
tion of mature T cells from human intrathymic T cell
precursors have been investigated, comparing them with those
promoted by IL-2. Our results show that adult CD3 - 4 - 8 -
thymocytes (preT cells) proliferate in vitro in response to IL4
through an IL-2-independent pathway. Moreover, IL4 stim-
ulation promotes the differentiation of preT cells into CD3+
mature T lymphocytes preferentially expressing TCR-y/6,
whereas mature T cells generated in response to IL-2 mostly
express the TCR-u/o . These results suggest that the selec-
tive use of either IL-4 or IL-2 pathways by T cell precursors
may be crucial in the generation of y/6 or a/o T cell line-
ages, respectively, during T cell development.
Materials and Methods
mAbs.
￿
Nal/34, anti-CDla(24); B9.4, anti-CD8 (25); HP2/6,
anti-CD4 (26);SPVT3b, anti-CD3 (27); 3A1, anti-CD7 (28); GAP
8.3, anti-CD45 (29); and W6/32, anti-HLA classI (A, B, C) (30)
mAbs were used as culture supernatants. MAR108, a mAb raised
against the p55-kD component of the IIL2R (26), waspurified by
protein A-Sepharose and conjugated with biotin. YTA1, a mAb
that appears to recognizethep75 IL2R component (31), was used
afterpurification by protein A-Sepharose. Edu-1, a monomorphic
mAb anti-HLA classII DR (32) and TCR-6-1mAbs, raised against
theSchain of theTCR-y/S(33),were obtained from ascites. WT31
mAbs, which recognize the TCRedia and 6TCS-1 mAbs, which
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(Uden, Holland) and T Cell Sciences (Cambridge, MA), respec-
tively. PE conjugated anti-CD1 and anti-CD2 mAbs were obtained
from Coulter Immunology (Hialeah, FL) and PE-coupled anti-CD3,
anti-CD4, and anti-CD8 mAbs, from Becton and Dickinson &
Co. (Mountain View, CA) .
Quantitative Flow Cytometry.
￿
Quantitation ofthe surface staining
of 5-10 x 10^ viable cells was performed with an Epics-Profile II
(Coulter Electronics, Hialeah, FL) flow cytometer. Cellular staining
was performed by indirect immunofluorescence at 4°C for 30 min
with saturating amounts of the corresponding mAbs, followed by
incubation with FITC-conjugated F(ab')z goat anti-mouse IgG
(Kallestad Laboratories, Inc., Austin, TX) used as second-step re-
agent in single stainings, as previously described (34). For dual pa-
rameter analysis, cells were further incubated with PE-conjugated
mAbs. Irrelevant isotype-matched mAbs from Becton and Dick-
inson & Co. were used as negative controls. The data were ana-
lyzed for representation using the Flowsys program developed by
Dr. L. Pezzi.
Isolation of Thymocyte Populations.
￿
Normal human thymocyte
suspensions were obtained from thymus fragments removed during
corrective cardiac surgery in patients 1 mo to 5 yr old. Viable thymo-
ryteswere isolated by Ficoll-Hypaque (Pharmacia Fine Chemicals,
Uppsala, Sweden) centrifugation. Intrathymic T cell precursors were
immunoselected by treatment with mAbs plus noncytotoxic rabbit
complement from Beringwerke (Marburg, FRG), as described be-
fore (34). Briefly, freshthymocytes were incubated with anti-CDIa
for 30 min at 4°C, followed by a 45-min incubation at 37°C with
a 1:5 dilution of complement. Recovered CD1- mature thymo-
ryteswere afterwards treated with anti-CD4, anti-CD8, and anti-
CD3 mAbs plus complement, in the same conditions, to obtain
preT cells (CD2' 1 -3 -4- 8- ). Viable cells were recovered by cen-
trifugation on Ficoll-Hypaque. Either mature thymocytes or preT
cells were further treated with the corresponding mAbs and in-
cubated for 30 min at 4°C with magnetic beads coated with affinity-
purified sheep anti-mouse IgG (Dynabeads M-450; Dynal, Oslo,
Norway), following the manufacturer's recommendations. As de-
scribed before (35), separation using this procedure allowed the
isolation of highly purified cell preparations (>99% pure) of ma-
ture thymorytes and preT cells.
Cell Cultures.
￿
Intrathymic subpopulations were cultured in 24-
well macroplates (Costar, Cambridge, MA) at 8 x 105 cells/ml
in RPM1-1640 (Gibco Laboratories, Grand Island, NY) sup-
plemented with 2 MM L-glutamine, 10 mM Hepes, 10% decom-
plemented pooled human AB serum, 100 U/ml penicillin, and 100
Ag/ml streptomycin in the presence of the indicated concentrations
ofrIIL2 (Hoffman-La Roche, Basel, Switzerland) or rIL4 (Sandoz,
Basel, Switzerland). Cell growth was followed by dailycounting
of viable cells under the microscope.
Proliferative responses were analyzed by methyl-['H] thymidine
incorporation. Cells were cultured in flat-bottomed 96-well mi-
crotiter plates (Costar) in 0.2 ml (106 cells/ml) of complete
medium either alone or supplemented with lymphokines, as indi-
cated in each assay. Proliferation was measured at different periods
of culture after addition of 1 P,Ci/well of ['H]thymidine (Amer-
sham Corp., Amersham, UK) for the last 16-24 h. Each value
represents the mean of triplicate cultures. The SDs were 415%.
The frequency of IL4-reactive human preT cells was evaluated by
limiting dilution analysis. Basically, preT cells were diluted in
medium containing 106/ml EBVtransformed B cells, limiting
the number of responding preT cells to around one, and grown
in Terasaki micro wells in 25 P,1 in the presence of rIL4. Frequen-
cies of 11,4-reactive preT cells were calculated from the number
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of cultured cells that were yielded in 63% ofall growing cultures,
and thus, contained one reactive cell.
Results
IL-4 Promotes the Proliferation ofHuman Intrathymic T Cell
Precursors. To investigate the capacity of 11,4 to induce growth
of humanT cell precursors, we isolated a highly purified popu-
lation (hereafter referred to as preT cells; reference 35) that
represents the 1-3% of total thymocytes. As shown in Fig.
1, this subpopulation displayed a marked expression of the
CD45 common antigen, whereas CD7 (known to be the
earliest T cell marker; reference 36) and CD2 molecules were
expressed on most (82 and 72%, respectively), but not all,
preT cells. Expression ofother T cell antigens, including CD1,
CD3, CD4, and CD8, as well as TCRcx/0 or -y/b struc-
tures, was not detected. In addition, very few cells (1%) were
stained with YTA1 mAb, which appears to recognize the
p75 component of the IL2R (IL2R-/3) (31), and a low IL
2R-a expression was detected (5%).
The proliferation of preT cells was assessed by [3H]thymi-
dine uptake after 4 d of culture with increasing amounts of
rIL4 . As shown in Fig. 2, rIL4 induces a dose-dependent
growth response in the absence ofmitogenic lectins or other
activation agents. Indeed, the addition of PMA to the cul-
tures set up in rIL4 did not significantly increase the IL4
promoted growth, although earlier response kinetics were
observed (data not shown).
Under these culture conditions, IL4 responsiveness was
also observed in mature thymorytes (CD1-3'4'/8+) (Fig.
3 A), as well as in double-negative (CD1 -3'4 - 8 -) and in
double-positive (CD1' 3' 4' 8') thymic subsets (A. B4rcena
et al., manuscript in preparation). However, proliferative re-
sponses displayed by immature preT cells were higher than
those observed for mature thymocytes (Fig. 3, A and C).
These data agree with previous results on the differential
growth requirements of early and mature intrathymic sub-
populations (37).
Studies on the kinetics of IL2- and IL4-induced responses
revealed different behaviors in preT cells. As shown in a rep-
resentative experiment depicted in Fig. 3 C, 11,4-promoted
responses were always delayed in comparison with those in-
duced by IL-2. Thus, maximal responses to 11,2 were observed
at day 3 of culture, whereas IL-4-promoted growth reached
maximal levels at day 7 in this particular experiment (Fig.
3 C). In contrast, the kinetics observed for mature T cells
in response to IL2 and IL4 were more similar (Fig. 3 A).
Cellular viability of preT cells was also scored over time in
parallel cultures set up either in IL-2 or IL-4. This study re-
vealed that an exponential growth with a calculated doubling
time of 48 h was sustained for 7-9 d in both culture condi-
tions. However, the IL-4-promoted growth declined afterthis
period, whereas proliferation induced by IL2 increased ex-
ponentially until day 9-12, and thereafter, cultures declined
steadily (35; and data not shown).
IL-4-mediated Proliferation ofPreT Cells Is Independent ofthe
IL-2 Pathway. Human T cell precursors have been shown
to constitutively produce IL-2, express variable levels of ILCONTROL CD45 CD7 CD1
CD4 CD8 Toc WT31
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2R, and, therefore, display an autocrine I1,2-supported growth
(37-39). To ascertain whether the growth of preT cells in-
duced by rIL4 was mediated by 11,2 produced in the cul-
tures, the proliferation ofpreT cells in response to either rIL4
or rIL2 was assayed in cultures set up in the presence or in
the absence of mAbs raised against the ci chain of the IL2R
(antiTac). As shown in Fig. 3, B and D, the anti Tac mAb
did not affect the proliferation induced by 11,4 in pre-T cells
and mature thymocytes (included as control in the assay).
The effectiveness of the antibody is demonstrated by the
marked inhibition of the IL2-promoted proliferation in both
populations. These data provide evidence for the involvement
of IL-4 in the growth and expansion of early human in-
trathymic T cell precursors by an IL-2-independent pathway.
IL-4 Promotes the Differentiation In Vitro ofPreT Cells into
Mature T Cells. Taking advantage of the observed role of
IL4 in promoting the proliferation ofintrathymic preT cells,
experiments were performed to analyze whether IL4 could
be also effective in inducing differentiation ofT cell precursors
in vitro. Acquisition of different T cell markers, including
CD4, CD8, and TCR, was assessed by flow cytometry, after
culture ofpreT cells with optimal doses of rIL4 (160 ng/ml).
Parallel studies were performed in cultures set up in the pres-
ence of rIL2 (50 u/ml), known to induce the maturation
in vitro of this intrathymic subset and the generation of both
CD4+ and CD8+ TCR-bearing mature T cell subsets (34).
PreT cells growing either in rIL4 or rIL2 gave rise to
mature T cellsmostly expressing CD3 molecules (Fig. 4 and
Table 1). However, significant differences with regard to the
95% 62%
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Figure 2.
￿
rIL4 promotes the
proliferation of CD7+CD2+
CD1 - 3 - 4 -8- preT cells in a
dose-dependent way. PreT cells
(106 cells/ml) were cultured in
RPMI medium, either with (")
or without (O) titrated amounts
of rIL4. Proliferation induced by
IL-2 (50 U/ml) was included as
control (L). [3H]Thymidine in-
corporation was quantitated at
day 4 in triplicate cultures.
Results are representative of four
independent experiments. SDs
were 415%.
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Figure 1.
￿
Phenotypic characteriza-
tion of human intrathymic preT
cells. Pre-T cells were isolated from
postnatal thymic samples, as de-
scribed in Materials and Methods.
After staining with the indicated
mAbs, immunofluorescence of 5 x
104 cells was quantitated in an
Epics-Profile II flow cytometer.
Staining with an irrelevant mouse
mAb was used as negative control.
development of the two major a/a and y/8 T cell lineages
were detected in both culture conditions. As shown in Fig.
4, while 85% of CD3+ T cells generated in the presence
of rIL4 expressed the TCR-y/b (recognized by TCR8-1
mAb), only 5% of cells were stained with antiTCR-ce//3
(WT31) mAb. Among TCRy/S+ cells, 46% of them used
the V61 gene segment, recognized by 6TCS-1 mAb (data
not shown). Analysis of the correlated expression of TCR
y/b vs. CD4 or CD8 accessory molecules indicated that
most TCR-y/S+ cells (46%) displayed a double-negative
(CD4 - CD8 - ) phenotype. In addition, CD8 + cells were
also observed among the TCRy/S+ subset (36%), while
no TCRy/S+ CD4+ cells were detected in different experi-
ments (Fig. 4). In contrast, both CD4+ and CD8+ mature
phenotypes were observed within the TCR-a/O+ popula-
tion (data not shown). The generation of a small number
ofTCRa/(3- vs. TCRy/6-bearing mature T cells was a con-
sistent finding in all cultures set up in the presence of rIL4.
Variable levels of TCR-ci/(3 expression (up to 25%) were de-
tected in other experiments (Table 1). In all of them, expres-
sion of the TCR-a/o paralleled the acquisition of the CD4
and CD8 molecules by preT cells, although a preferential
differentiation into CD8+ cells was consistently observed
(Table 1). In addition to CD4+ and CD8+ TCRci/O+ ma-
ture T cells, TCR-ac/a+ thymocytes were also observed
within the CD4- CD8 - population (data not shown).
Regarding the expression of CD2 molecules in the IL4-
induced preT cell progeny, also worthy of note is the obser-
vation of a variable proportion of cells (20% in this experi-
ment; Fig. 4), characterized by the expression of the TCR
complex, in the absence of CD2 antigens (CD2 - CD3 +).
Assuming that the frequency of TCRa/a+ cells is 5% of
total cells, the CD2 - CD3+ subpopulation will be mainly
constituted by TCR-y/S+-bearing T cells.
Analyses of the distribution of the two types of TCRs in
cultures set up in the presence of rIL2 revealed results oppo-
site to those observed with rIL4. TCRa/a+ cells, ex-
pressing either CD4 or CD8 molecules, accounted for the
majority of CD3+ thymocytes (85%) generated in rIL2, al-
though TCR-y/S+ cells were also detected (12%) (Table 1).
Both CD4+ and CD8+ TCR-a/(3+ populations were ob-
served in these cultures. However, CD4+ cells (84%)
(bearing the TCR-a/(3 complex, data not shown) were
significantly expanded in contrast to the preferential differen-
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tiation into CD8+ cells detected in cultures set up with
rIL4 (Fig . 4 and Table 1) . As observed with rIL4, a signi-
ficant proportion ofTCR-y/6+ cells generated in rIL2 ex-
pressed CD8 molecules, whereas most of them were included
within the CD4-CD8 - subset, and no CD4+ TCR-y/6+
cells were detected (data not shown) .
In light of previous studies (39) showing that activation
of IL2R-a genes is induced in vitro in T cell precursors
growing in rIL2, experiments were performed to ascertain
whether upregulation ofIL2R was also involved in the 1174-
induced differentiation process . Phenotypic analyses of the
expression of both a and 0 IL-2R components revealed that,
in contrast to the high expression of IL2R-a observed after
culture in the presence of rIL2, very low levels of IL2R-a
molecules were displayed by pre-T cells cultured with rIL4
(Table 1) . However, reactivity withYTA-1 mAb was observed
in most ofpre-T cells (95%) cultured with rIL4, even when
IL2R-a expression was not detectable (Fig . 4), as well as
in IL2-cultured preT cells (Table 1) . In both differentiation
systems, expression ofIL2R-a correlated with the levels of
HLA-DR molecules induced in preT cells (Table 1) .
Finally, the fact that 1174 promotes the differentiation of
preT cells preferentially into TCR-y/6-bearing T cells led
us to investigate the ability of this lymphokine to induce the
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Figure 3 .
￿
Proliferation of mature thymocytes and
preT cells in response to rIL4 vs rIIL2 . Mature
thymocytes (A and B) and preT cells (C and D) (106
cells/ml) were cultured in medium (p, /) rIL4 (160
ng/ml) (A, A), or rIL2 (50 U/ml) (O, 0) either in
the presence (open symbols) or in the absence (filled
syntbols) of 1:200 dilution of antiTac mAb (H108) .
Proliferation was quantitated by [3H]thymidine uptake
at the indicated days of culture. Results are represen-
tative of three independent experiments .
selective proliferation of TCR--y/S+ mature T cells from
PBL . To this end, we chose a normal healthy donor possessing
a high frequency of 'y/6 + T cells (20% of total lympho-
cytes) . PBL were cultured in presence of 160 ng/ml of rIL4
and 70 U/ml of rIL2, the latter included as a control of
experiment . The proliferation of the cells, assessed by [3H]thy-
midine uptake, and the phenotypic distribution of theTCR-
a/(3+- and -y/6+-bearing T cells (assessed by flow cytom-
etry) took place after 4 and 7 d of culture .
The results of a representative experiment are shown in
Table 2 . The peripheral blood mature T cells do not grow
in response to 11,4, and the frequency ofTCR-y/6+ T cells
was not modified after culture with this lymphokine. In con-
trasts, the IL-2-promoted proliferation of PBL is parallel to
a selective expansion ofTCR-y/6+ T cells, as previously de-
scribed (40) . These results demonstrate that the appearance
of y/6+ T cells in the progeny of IL-4- cultured preT cells
cannot be explained by the overgrowth of small mature con-
taminantT cells. Therefore, an I14-promoted differentiation
of preT cells into TCR-y/6+-bearing T cells is required .
To formally rule out that outgrowth of rare contaminants
with mature phenotype can account for the differentiation
of preT cells upon in vitro culture with 11,4, we have under-
taken the following set of experiments : (a) daily character-
Figure 4.
￿
In vitro differentiation of human
preT cells cultured with IIA . PreT cells im-
munoselected from fresh adult human thymo-
cytes were cultured at 2 x 106 cells/ml in
medium containing 160 ng/ml of rllJ4 . Cellular
staining was performed, as described in Materials
and Methods, at day 9 of culture with the indi-
cated mAbs . Two-color immunofluorescence
analyses of 2 x 10 4 viable cells were performed
in an Epics-Profile II flow cytometer. The
number of positive cells over background
stainings observed with irrelevant mAbs are rep-
resented . The data were analyzed for representa-
tion using the FlowSys program.
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￿
Diferentiation In Vitro of Intrathymic Pre-T Cells in rIL-4 and rIL-2
Pre-T cells (2 x 106 cells/ml) were cultured in complete medium supplemented with 160 ng/ml of rIL-4 or 50 U/ml of rIL-2. The pheno-
type of the cells was assessed by direct or indirect immunofluorescence and quantitative flow cytometry (Epics-Profile II). Results show the
percentage of cells positive for each marker.
" Cell recovery is the cell number after 14 d culture/initial cell number.
ization of the growing T cells; and (b) repeating of the ex-
periments under limiting dilution conditions. The results
depicted in Fig. 5 allow us to draw the following conclu-
sions. Theextrapolation oftime zero oftheexponential growth
curves of the cultures reveals that the number of growth-
initiating Tcell precursors perculture ranges from 10 to 20%
of the starting cells (Fig. 5 B), which agrees with the fre-
quency of responding cells in cultures performed under lim-
iting dilution conditions (Fig. 5 A) (5-15%). Interestingly
enough, the frequency of growth-initiating preT cells per
culture in thepresence of IL -2 or IL-4 is the same (not shown).
However, the doubling time and the clone size of platted
cells in both types of cultures is quite different. Thus, while
in the presence of IL-2 pre-T cells divide every 36-40 h, in
the presence of IL4, thedoubling time is 48-50 h. This divi-
sion time agrees with the measures obtained in mass cell cul-
tures. Early phenotypic characterization of clones derivedby
limiting dilution analysis showed amore frequent differenti-
ation into the MR.-y/6-bearing lymphocytes. In fact, the
phenotypic characterization of theproportion oflimiting di-
lution cultures yield 70-80% and 20-30% of TCR-y/S- and
ot/0-bearing lymphocytes, respectively.
PBL (5 x 105 cells/ml) were cultured in complete medium supplemented with 160 ng/ml of rIL-4 or 70 U/ml of rIL-2. The proliferative
responses were analyzed at indicated days of triplicate cultures after addition of 1 ,ACi/well of [3H]thymidine for the last 18 h, and the pheno-
type of the cells was assessed by direct or indirect immunofluorescence and quantitative flow cytometry. The results show the percentage of
cells positive for each marker.
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Discussion
Recent studies of embryonicand adult humanthymus have
identified CD45+7+2+1 -3-4-8- preT cells as an early on-
togenic subset comprising the precursors of mature T cells
(34, 36). At present, the regulation of the complex process
leading to TCR rearrangement and differentiation of T cell
precursors into CD3+ mature T cells remains poorly under-
stood. In humans, thedevelopment ofin vitromodelsystems
of differentiation has been a useful tool to study cellular and
molecularevents involved in such aprocess. From these studies,
evidence has been obtained forthe role that the 11,2 pathway
plays in the generation of both TCR-o:/(3- and TCR-'y/6-
bearing T cell lineages (41) . In addition, recent reports in
mice showing that intrathymic T cell precursors are able to
produce (19, 22) and respond to (19-21) IL4 after cellular
stimulation indicate that IL4 couldbe an alternative growth
factor to IL2, involved in T cell differentiation.
In this study, in vitro differentiation approaches, similar
to those previously describedfor 11,2 (34, 39), have been used
to analyze thepotential effects of IL-4 on human preT cells.
Our results show that preT cells are able to proliferate in
response to rIL4 in adose-dependent way. Although theability
Table 2. Phenotypic Analysis and Proliferation of PBL Cultured in rIL-2 and rIL-4
Day of
culture
Culture
conditions
[3H]Thymidine
uptake CD45 CD2
Expression
CD3
of surface T
CD4
cell markers
CD8 WT31 6-1
cpm %
0 - - 93 76 74 40 15 63 18
4 rIL-4 300 ± 29 97 80 77 50 20 57 19
4 rIL-2 44,428 ± 600 96 86 84 44 28 67 20
7 rIL-4 971 ± 147 98 94 90 47 25 77 19
7 rIL-2 135,501 ± 2,136 98 96 82 17 35 45 35
Culture
conditions
Day of
culture
Cell
recovery" CD45 CD7 CD1 CD2
Expression
CD3
of
CD4
surface T
CD8
cell
WT31
markers
6-1 TAC YTA-1 HLA-DR
- 0 86 55 <1 52 <1 <1 <1 <1 <1 5 14 35
rIL-4 14 175 99 98 ND 100 80 26 49 25 60 12 98 30
rIL-2 14 233 99 99 ND 100 97 84 20 85 12 67 95 59rc
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Figure 5.
￿
(A) Titration of IL-
4-reactive human preT cells.
The indicated number of cells
B
￿
were grown in the presence
(filled symbols) or in the absence
(open symbols) of 160 ng/ml of
IL4. Each point in the figure is
based on assays of 60 cultures.
(B) Growth of IL-4-reactive
human preT cells. Human preT
cells (8 x 105/ml) were in-
cubated in the presence (filled
symbols) or in the absence (open
symbols) of 160 ng/ml of rIL4,
and the increase in cell number
was measured with time of
stimulation.
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of IL4 to promote proliferation ofpostnatal immature thymo-
cytes in mice is well documented (19, 20, 42), in all cases
so far reported, 114-induced proliferation required cellular
activation with mitogenic agents. In contrast, human preT
cells did not appear to require costimulatory signals to re-
spond to 11,4, and, indeed, addition of PMA to the cultures
did not significantly increase IL4-promoted growth (data not
shown). These findings must be discussed in the light of re-
cent studies showing that mouse CD4-CD8- T cell pre-
cursors constitutively expressed low levels of high affinity
receptors for IL4, which increased approximately eightfold
after cellular activation with PMA (20). These data suggest
that functional levels of IL4R, capable of mediating growth
signal transduction, may be expressed constitutively on human
preT cells. In agreement, 11,4-promoted proliferation of mouse
fetal thymocytes has been reported at the clonal level (43,
44). Alternatively, IL4/IIr4R interaction on preT cells may
result in an upregulation of high affinity IL4R, leading to
cellular proliferation. The recent observation that 11,4 alone
is able to induce IIr4R expression on human PBMC at levels
similar to those obtained by anti-CD3 activation (45) fur-
ther supports the latter hypothesis. Therefore, availability of
IL4 within the thymic microenvironment appears to be crit-
ical in the regulation of the physiological growth responses
mediated by IL4. Results showing that by 15 d of gestation
in the mouse up to 45% of thymocytes constitutively pro-
duced IL4 mRNA (23) provide evidence for the involvement
of 114 in the proliferation of T cell precursors, as proposed
earlier for 11,2 (35, 41) .
Analyses of the growth-promoting effect of 114 on pre-T
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cells revealed that this process must be independent of the
11,2 pathway. In fact, antibodies specific for the a compo-
nent of the IIr2R were not able to block the proliferation
induced by IL4. However, recent studies showing that IL4
downregulates the number of high affinity I1r2Rs in B and
T cell lines suggested an interaction between the two pathways
(46). This possibility could explain the synergistic effect of
both lymphokines on the proliferative response induced in
T cells (14, 46, 47). Whether or not 114 is also responsible
for the low IL2Ra expression detected in the pro-T cell
progeny remains to be established. The answer to this issue
must wait until much more information on the populations
of T cell precursors responding to 11,4 and 11,2 is available.
Therefore, different T cell precursor subsets may respond to
distinct lymphokines, or, alternatively, the same intrathymic
population may utilize both growth pathways. To date, evi-
dence obtained at the clonal level with 14-d fetal thymocytes
indicates that the same fetal precursor can use both IL2 and
11,4 as growth factor (43, 44) .
Results reported here suggest that humanearly intrathymic
T cell precursors are able to respond to both lymphokine
pathways. Our data showed that IL4 responsiveness resulted
not only in proliferation but also in differentiation of preT
cells. Moreover, a predominant differentiation of preT cells
into TCR-,y/6' -bearing mature T cells was induced by IL4,
whereas IL2-responding preT cells preferentially differentiate
into TCR-a/(3+ T cells.
A common question that arises upon analysis of pre-T cell
cultures concerns the possibility that mature cells escape both
antibody plus complement and magnetic beads coated with
anti-mouse Ig treatments in the starting population, and ex-
pand to account for the phenotypic pattern observed. The
following findings, presented here and elsewhere (39), cannot
be easily reconciled with such an interpretation. First, precursor
and mature populations were distinct with regard to their
expression of CD3, CD4, CD7, CD8, and CD45 antigens.
Second, the expression of CD3 antigen clearly precedes that
of CD4 and CD8. Third, as shown here, mature y/S T cells
do not grow in 114. Fourth, effector function, mainly killing
activity, was acquired after 4 d in culture, at which point
the activity per cell rose 250-fold in 2 d (data not shown).
Fifth, the frequency of responding cells, calculated by lim-
iting dilution analysis and by the extrapolation to day 0 of
the exponential growth curves, is at least 20-40 times higher
than the number of possible contaminants detected by flow
cytometry. Sixth, the production of IL4 and the expression
of IIr4R by thymic preT cells and not by mature thymo-
cytes (J. L. de la Pompa et al., manuscript in preparation) .
Our data can be interpreted on the basis of the differences
in the kinetics offetal thymocytes expressing IIr4R and pro-
ducing 11,4 or 111,2 in ontogeny (23), as well as ofthe develop-
mental regulation of TCR-y/S and -a/R gene expression.
We proposed that two different pathways may be involved
in the generation of mature T cells from intrathymic
precursors. At early stages ofdevelopment, availability of IL4
within the thymic microenvironment would induce IIr4R-
bearing progenitors to grow and to differentiate preferentiallyinto TCR-y/S+ cells. Later on, activation of the Ilr2 path-
way (ID2 production and IIr2R expression) would result in
generation of TCR-ot/,(3+ cells. The reported involvement
of an 111r2-dependent autocrine pathway of growth in T cell
development (39) suggests a similar autocrine behavior for
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